The findings provided an innovative insight into the treatment using Ginkgolide B as a therapeutic in Aβ1‑42‑related Alzheimer’s disease.

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.